Doctors Note Logo

Published on: 9/23/2026

How often is the RSV vaccine repeated?

For most adults, the RSV vaccine is currently given as a single lifetime dose rather than repeated every year, and people who have already received one are not advised to get another at this time. Timing differs for pregnancy (one dose in a defined window during the season) and for infants, who may receive a protective antibody injection each RSV season, and future booster guidance may change as research continues. Several factors affect whether and when you might need another dose, including your age, health conditions, and when your first dose was given, so review the complete details below before deciding.

If you are coughing, wheezing, or feeling feverish and unsure whether RSV, flu, or COVID could be behind it, guessing can delay care that works best early. A free, instant, online symptom check can help you understand what your symptoms may point to and what sensible next steps look like, in just a few minutes and without leaving home.

Last reviewed for medical accuracy: 09/23/2026

answer background

Explanation

How Often Is the RSV Vaccine Repeated?

Respiratory syncytial virus (RSV) can cause serious lung infections, especially in older adults and young children. With the recent approval of RSV vaccines for adults and pregnant people, many are asking: “RSV vaccine how often do I need it?” Below is a clear, up-to-date overview based on CDC and FDA guidance.

Who Should Get an RSV Vaccine?

  1. Adults 60 and older
    The U.S. Food and Drug Administration (FDA) has approved two RSV vaccines—Arexvy (GSK) and Abrysvo (Pfizer)—for people aged 60 and up.
  2. Pregnant people
    Abrysvo is also approved for pregnant individuals between 32 and 36 weeks of gestation to protect newborns in their first months of life.
  3. Future approvals
    Research continues on vaccines for infants and toddlers; for now, monoclonal antibodies (like nirsevimab) are used in high-risk infants.

RSV Vaccine Schedule: How Often?

For Adults Aged 60 and Older

  • One dose per RSV season
    ACIP (Advisory Committee on Immunization Practices) recommends a single dose before the start of each RSV season.
  • Why annual?
    • Immunity may wane over time.
    • RSV strains can change from year to year.
    • Annual dosing mirrors flu-shot timing (fall), making it easier for clinics to coordinate both vaccines.

At this point, there’s no recommendation for more than one dose within a single season. Future data may refine timing or booster needs.

For Pregnant People

  • One dose per pregnancy
    Vaccinate between 32 and 36 weeks gestation to maximize antibody transfer to the fetus.
  • Repeat each pregnancy
    If you become pregnant again in a later season, you should receive the vaccine again between weeks 32 and 36.

For Infants and Young Children

Currently, vaccines are not approved for infants. Instead, high-risk babies (preterm, certain heart or lung conditions) may receive nirsevimab, a long-acting antibody. This is given as:

  • A single dose before the RSV season
  • Protection lasts about 5 months, covering the height of RSV activity

Check with your pediatrician to see if your child qualifies.

Common Questions

1. Why not just one lifetime dose?

  • RSV immunity is not lifelong.
  • Viruses evolve; annual vaccination helps match circulating strains.
  • Annual boosting is similar to other respiratory vaccines (e.g., influenza).

2. Can I get my flu shot and RSV vaccine together?

  • Yes. Studies show they can be given at the same visit.
  • This reduces the number of clinic trips and ensures broader protection against respiratory viruses.

3. What about side effects?

Most people tolerate the RSV vaccine well. Common side effects include:

  • Mild pain or redness at the injection site
  • Muscle aches
  • Fatigue
  • Headache

These generally resolve in a day or two. Serious allergic reactions are rare.

4. What if I miss the start of RSV season?

  • Get vaccinated as soon as possible.
  • Protection begins about two weeks after the shot.
  • You don’t need to wait for the next season—catch-up vaccination is recommended.

Planning Your RSV Vaccine

  • Talk to your primary care doctor or pharmacist in late summer or early fall.
  • Coordinate with your annual flu shot for convenience.
  • If you’re pregnant, schedule with your obstetrician between weeks 32–36.

Monitoring Symptoms

Even with vaccination, no vaccine is 100% effective. If you develop cough, fever, wheezing or difficulty breathing:

Why Annual RSV Vaccination Matters

  • Reduces hospitalizations. Older adults and infants face the highest risk.
  • Lowers health-care burden. Fewer ER visits and nursing-home outbreaks.
  • Protects vulnerable communities. Annual coverage builds herd immunity.

Talk to Your Doctor

Guidelines evolve as more data emerge. Always discuss with your health-care provider:

  • Whether you fall into a recommended group
  • The best timing for your vaccine
  • Any concerns about side effects or interactions with other vaccines

If you have a medical emergency (severe difficulty breathing, chest pain, sudden confusion), seek immediate care or call emergency services.


Staying up to date on your RSV vaccine—especially if you’re 60 or older or pregnant—can help keep you and your loved ones healthier through RSV season. Always “speak to a doctor” about any serious or life-threatening concerns.

(References)

  • * Chu HY, Englund JA. Maternal immunization. Birth Defects Res. 2017 Mar 15;109(5):379-386. doi: 10.1002/bdra.23547. PMID: 28398678.

  • * Simões EAF, Center KJ, Tita ATN, Swanson KA, Radley D, Houghton J, McGrory SB, Gomme E, Anderson M, Roberts JP, Scott DA, Jansen KU, Gruber WC, Dormitzer PR, Gurtman AC. Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy. N Engl J Med. 2022 Apr 28;386(17):1615-1626. doi: 10.1056/NEJMoa2106062. PMID: 35476650.

  • * Lu BN, Zhu KL, Cui XM, Yao L, Wang XJ, Wang GL, Duan LJ, Qian A, Ma MJ. Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors. Clin Immunol. 2022 Nov;244:109103. doi: 10.1016/j.clim.2022.109103. Epub 2022 Aug 29. PMID: 36049602; PMCID: PMC9423872.

  • * Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 Study Group. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. PMID: 38253338; PMCID: PMC11175669.

  • * Blauvelt CA, Zeme M, Natarajan A, Epstein A, Roh ME, Morales A, Bourdoud N, Flaherman VJ, Prahl MK, Gaw SL. Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates. JAMA Netw Open. 2025 Feb 3;8(2):e2460735. doi: 10.1001/jamanetworkopen.2024.60735. Epub 2025 Feb 3. PMID: 39969879; PMCID: PMC11840647.

  • * Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Cuadripani S, Deraedt Q, Dezutter N, Gerard C, Fissette L, Xavier S, David MP, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 study group. Efficacy, safety, and immunogenicity of the AS01(E)-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2025 Jun;13(6):517-529. doi: 10.1016/S2213-2600(25)00048-7. Epub 2025 Apr 14. PMID: 40245915.

  • * Surie D, Self WH, Yuengling KA, Lauring AS, Zhu Y, Safdar B, Ginde AA, Simon SJ, Peltan ID, Brown SM, Gaglani M, Ghamande S, Columbus C, Mohr NM, Gibbs KW, Hager DN, Prekker M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Gordon AJ, Qadir N, Chang SY, Mallow C, Felzer JR, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Papalambros L, Mosier JM, Harris ES, Baughman A, Cornelison SA, Blair PW, Johnson CA, Lewis NM, Ellington S, Grijalva CG, Talbot HK, Casey JD, Halasa N, Chappell JD, Rutkowski RE, Ma KC, Dawood FS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28;334(16):1442-1451. doi: 10.1001/jama.2025.15896. PMID: 40884491; PMCID: PMC12398767.

  • * Ruuskanen O, Valtonen M, Heinonen OJ, Waris M, Mertsola J. Vaccinations for Elite Athletes. Vaccines (Basel). 2025 Aug 31;13(9). doi: 10.3390/vaccines13090931. Epub 2025 Aug 31. PMID: 41012134; PMCID: PMC12474241.

  • * Saif-Ur-Rahman KM, King C, Whelan SO, Blair M, Donohue S, Madden C, Kothari K, Sommer I, Harder T, Dauby N, Moustsen-Helms IR, Ruta S, Frère J, Schönfeld V, Poukka E, Lutsar I, Olsson K, Melidou A, Adel Ali K, Dwan K, Devane D. Efficacy and safety of respiratory syncytial virus vaccines. Cochrane Database Syst Rev. 2025 Sep 29;9(9):CD016131. doi: 10.1002/14651858.CD016131. Epub 2025 Sep 29. PMID: 41016728; PMCID: PMC12476935.

  • * Höck M, Borena W, Brunner J, Wechselberger K, Scheiring J, Ralser E, Pupp Peglow U, Wöckinger P, D'Costa E, Kaiser V, Kapelari K, Gerold G, Müller T, Kiechl-Kohlendorfer U, Griesmaier E. Acceptance and impact of Nirsevimab and the RSVpreF vaccine following implementation in Austria. Front Public Health. 2025;13:1686581. doi: 10.3389/fpubh.2025.1686581. Epub 2025 Oct 20. PMID: 41189975; PMCID: PMC12580268.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.